Popular Articles

Provectus Pharmaceuticals Initiates New PH-10 Clinical Study For Psoriasis
Provectus Pharmaceuticals, Inc. (OTC BB: PVCT ), a development-stage oncology and dermatology biopharmaceutical company, has initiated a new Phase 2 clinical trial of PH-10 for psoriasis involving daily dosing of patients for 28 days. After reviewing safety and efficacy data from its PH-10 trial for atopic dermatitis, Provectus determined that daily dosing of patients with psoriasis trial would be an appropriate and attractive regimen. The new study supplants an earlier Phase 2 study, using twice weekly dosing for 12 weeks, which was terminated earlier in June.
drugs without prescription
Pakistan Receives Grants To Fight TB, Infant, Maternal Mortality, Health Minister Says
Pakistan has obtained international support for its efforts to fight tuberculosis and lower infant and maternal mortality rates, Mir Aijaz Hussain Jakhrani, the health minister, said recently after returning from the 62nd World Health Assembly (WHA), the International News reports.
News of the day
Promising Results With Aleglitazar, A New Treatment Drug For Type 2 Diabetes (SYNCHRONY Study)
The results from the phase II SYNCHRONY study are published in an article Online First and in a future edition of The Lancet. At the same time, the findings are presented at the American Diabetes Association meeting in New Orleans, USA. They suggest that aleglitazar, a treatment for type 2 diabetes, might be safe and effective and may perhaps be introduced into phase III trials.
Public Health

Patients To Have Their Say On Infertility Treatment In Scotland

Infertility Network Scotland has welcomed the announcement by the Public Health Minister, Shona Robison, that over the next three years the Scottish Government will provide funding to Infertility Network Scotland to work with Health Boards to help them to address the inequity of access that has existed in Scotland for too many years. We also welcomed the news that an expert advisory group will be established this summer to consider an action plan on infertility services. Sheena Young, Head of Business development for Infertility Network Scotland said "Infertility Network Scotland which is a branch of the national charity Infertility Network UK was recently set up to ensure patients in Scotland had their own Scottish identify. Infertility Network Scotland is committed to the provision of patient information and support and, working with the National Infertility Awareness Campaign (NIAC), has long campaigned for the end to the postcode lottery that exists for infertility sufferers in some areas. We are delighted to be asked by The Scottish Government to undertake this work with Health Boards in Scotland to address issues about funding and criteria for fertility treatment. It is important that everyone in Scotland has fair and equal access to treatment which is what this project aims to achieve." Patients can access up to date information on the NHS treatment provided by all the Health Boards through the new Funding for Fertility section of our website - visit http://www.fundingforfertility.co.uk for full details. Infertility Network Scotland


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):